Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Related Articles
Commentaries
MAKE A COMMENT
All fields requiredMore Views
- Cuba explores technique to reduce vector population
- UN warns that nearly 55 million face hunger in West and Central Africa
- Extradition of Julian Assange edges closer as U.S. claims it will respect his human rights
- Artificial intelligence platform is developed in Cuba
- FAO assists Cuba in forest protection